Nobo Healthcare Completes Series B Financing of Several Hundred Million RMB to Advance Smart Hospital IoT Platform

VCBeat (WeChat ID: vcbeat) has learned that Shenzhen Nuo Bo Medical Technology Co., Ltd. (“Nuo Bo Medical”), a leading domestic provider of integrated hardware and software solutions for IoT-based smart hospitals, announced today the completion of its Series B financing round, amounting to hundreds of millions of RMB. The round was led by SAIF Partners Asia, with participation from HTI, Jiaming Haochun, and Jiufeite. CEC CAPITAL served as the exclusive financial advisor to Nuo Bo Medical in this transaction.

The proceeds from this round of financing will be primarily used for the iterative upgrade of the company’s existing products and the expansion of new product lines, the recruitment of high-tech R&D talent, the expansion of domestic and international markets, and the upgrading of sales networks.

Founded in 2012, Nuo Bo Medical provides hospitals with an integrated hardware and software management solution for pharmaceuticals and medical consumables, covering the entire process from suppliers to bedside use through IoT, intelligent sensing, and core algorithm technologies. Leveraging this as a starting point, the company continuously develops products and expands its product line around scenarios such as smart wards and smart operating rooms, thereby building an IoT platform for smart hospitals.

The company’s Smart Hospital IoT Platform centers on a device middleware and a hospital closed-loop data platform. It develops a series of intelligent hardware devices to collect clinical and management data in real time, optimizes workflows across internal and external departments through system software, facilitates seamless data flow, and builds a unified data platform that integrates seamlessly with the hospital’s existing information systems.

Nobo Medical is the first company in China to implement an enterprise-wide intelligent medication management solution and remains the only player in the industry to have successfully expanded into overseas markets, demonstrating global vision and product competitiveness. The company operates three R&D centers in Shenzhen, Hefei, and Irvine, California (USA). Its products have been deployed in more than 1,500 hospitals, covering over 10 countries and regions worldwide. Amidst the 2020 pandemic and the current global political and economic landscape, the company has been awarded contracts and included in the procurement whitelists of healthcare groups and government agencies in countries such as Singapore and Australia, earning recognition from international clients.

With the deployment of 5G, the Internet of Things (IoT) will see widespread adoption and application across various sectors, presenting new opportunities for iterative upgrades in healthcare settings. Meanwhile, efforts to enhance hospital informatization and intelligence through software have reached a mature stage. Integrated hardware-software solutions based on IoT technology—such as smart devices for automated data collection—can better assist hospitals in optimizing workflows, ensuring compliance and security, improving efficiency, and enhancing the quality of medical care. In the future, the company will focus on healthcare scenarios, address the pain points of clinical staff and patients, and launch a series of products to build an IoT ecosystem for smart hospitals.

Zhou Xinghan, Founder of Nuo Bo MedicalHe stated, “The market for smart hospital development is expanding rapidly. Especially in the post-pandemic era, hospitals’ demands and requirements for intelligence and informatization have reached a new height. In the process of collaborating with hospitals to build smart systems, I have deeply felt that the speed of product research, development, and market launch falls far short of meeting current hospital needs. Hospital management departments are willing to actively try new products and solutions to continuously enhance their level of intelligence. Thanks to the support from both new and existing shareholders, we are able to delve deeper into the clinical frontline with greater speed and higher technical standards, developing a series of products that address actual pain points, empowering hospitals, facilitating the smart transformation of hospitals both domestically and internationally, and creating value for healthcare professionals and patients.”

Xu Hang, Senior Partner at SAIF Partners“The development of China’s economy, rising consumption levels, and population aging have significantly exacerbated the shortage of medical resources and intensified pressure on healthcare cost containment. Meanwhile, leveraging technologies such as the Internet of Things (IoT), intelligent sensing, and big data to digitally transform and upgrade traditional hospitals can deliver more convenient medical services to patients, alleviate the workload of healthcare professionals, improve hospital operational and management efficiency, and enable more efficient utilization of medical resources. This niche sector is still in its early stages of rapid growth and has the potential to evolve into a market worth hundreds of billions of yuan. NuoBo boasts strong integrated R&D capabilities in both hardware and software, possesses a deep understanding of clinical needs, and is one of the few companies in the industry with global competitiveness that has successfully expanded into overseas markets. These strengths give Saifu Medical’s team great confidence and high expectations for NuoBo’s future development in the smart hospital construction space. Following this round of financing, Saifu will work alongside other shareholders to provide post-investment value-added support to NuoBo, helping propel it toward becoming a great company.”

Zhu Zhaohui, General Manager of Shenzhen HTI Venture CapitalIt stated: “Smart healthcare is poised to become a market worth hundreds of billions, with rapid industry growth. Essentially, smart healthcare represents the new generation of medical informatization, primarily involving refined management applications such as medical supply chain optimization, cost control, and efficiency enhancement. It constitutes a new-generation informatization upgrade focused on internal hospital controls, emphasizing standardized and process-oriented operations. Nuo Bo Medical first captured market share through mobile terminal hardware, then built a hospital-wide platform for end-to-end management of pharmaceuticals and consumables, while also laying out its smart ward product line and constructing smart hospitals. Nuo Bo Medical enables hospitals to eliminate information silos, standardize the practices of medical staff, improve work efficiency, and control costs. HTI will fully leverage the advantages of integrated insurance and investment linkage to support Nuo Bo Medical’s financing and investment services, empower innovators, and help enterprises achieve faster and better development.”

Tan Hao, Founding Partner of Dong Ting Lake Capital Management Company Ltd.He stated, “After decades of development, China’s level of healthcare informatization has continuously improved, and a market landscape dominated by systems such as HIS and CIS has initially taken shape. In the future, hospital development in China will transition from informatization to intelligentization. This process will require the introduction of next-generation digital systems built upon the aforementioned infrastructure, breaking down the barriers between business processes and physical workflows to make hospital management more transparent, efficient, and intelligent. Jiaming Haochun looks forward to partnering with next-generation smart hospital solution providers like Nuobo, which offer integrated software-hardware solutions, to jointly promote the construction and rapid development of smart hospitals in China by leveraging emerging technologies such as advanced IoT, artificial intelligence, and big data.”

Lin Hengcong, General Manager of Jiufeitestated: “Prior to the implementation of the ‘Two-Invoice System’ and the zero-markup policy, markups on pharmaceuticals and consumables masked the extensive and inefficient management of in-hospital supplies. Traditional hospital management practices posed safety risks and suffered from low efficiency. There is an urgent need for hospitals to leverage technological means to achieve refined supply chain management, ensure regulatory compliance and clinical medication safety, improve operational efficiency, allow medical professionals to refocus on core clinical duties, and enhance the quality of care. As a leading domestic provider of integrated hardware and software solutions for IoT-based smart hospitals, Nubo Medical’s products and services precisely meet the current pressing demands of smart hospital development. We look forward to Nubo Medical’s continued deep engagement in the informatization and intelligent transformation of smart hospitals, positioning it as an industry leader.”

As the exclusive financial advisor for this transaction,Wang Bin, Managing Director of CEC CAPITALHe stated, “Currently, the intelligent construction of hospital information systems in China remains largely at a basic level, focusing on financial management, medical record information, and the transmission of laboratory and imaging results. However, given the inevitable trend toward safer, more efficient, intensive, and environmentally friendly hospital operations and management, more advanced informatization and intelligence will certainly be adopted in areas such as medication safety, personalized patient management, and in-hospital logistics and quality control. This represents a significant opportunity for Nuo Bo. Shenzhen Nuo Bo Medical Technology Co., Ltd. boasts an overseas R&D team well-versed in the practices of leading international hospitals, proprietary algorithmic software, and highly adaptable hardware products, positioning it at the forefront of the industry. We look forward to accompanying Nuo Bo on its journey to even greater success.”

SAIF Partners, established in 2001, is a private equity firm providing financial support to high-growth enterprises in the Asia-Pacific region. Previously affiliated with Japan’s SoftBank until 2004, it became independent in 2005. Currently, SAIF manages USD and RMB funds with a total asset under management (AUM) of nearly RMB 70 billion. The firm has invested in and managed nearly 400 companies, including dozens that are listed on domestic and international stock exchanges, with another dozen preparing for IPOs both domestically and abroad. SAIF boasts a professional team of nearly 80 highly qualified and experienced members who have collaborated for many years. From 2004 to 2020, SAIF was consecutively rated as the Best Venture Capital Institution by authoritative industry research organizations.

Shenzhen HTI, established in 1994, is a professional financial services institution founded by the Shenzhen Municipal Party Committee and Municipal Government to address financing difficulties faced by small and medium-sized technology enterprises. It holds the highest AAA credit rating for capital market entities. Currently, the Group has paid-in capital of RMB 13.8 billion, net assets exceeding RMB 22 billion, and total assets approaching RMB 34 billion. Its business scope covers bank loan guarantees, engineering guarantees, bond credit enhancement, venture capital, fund management, micro-lending and pawnbroking, commercial factoring, and more, providing comprehensive investment and financing services to enterprises from their start-up to maturity stages. Over the past two decades, Shenzhen HTI has remained committed to serving small, micro, and technology-based enterprises, growing alongside them. Companies it has supported, such as Huawei, BYD, Skyworth, Han’s Laser, and Hytera, have become well-known domestic and international brands. High-tech enterprises like Woer Nuclear Material, Fastprint Circuit Tech, O-film Tech, and Dongjiang Environmental have emerged as industry leaders. More than 300 companies domestically and abroad that have gone public with its support are referred to by the media as the “HTI Cluster” in the capital markets.

Dong Ting Lake Capital Management Company Ltd. was established in May 2015 and currently manages four RMB-denominated funds. Focusing on innovative technology investments in the B2B sector, the firm has invested in dozens of outstanding enterprises that have garnered significant industry attention in fields such as big data, cloud computing, artificial intelligence, next-generation communication technologies, and information security. Some of its portfolio companies have already been listed on the ChiNext Board or the STAR Market, or have passed the review of the Listing Committee. Adhering to a value-driven investment philosophy, Dong Ting Lake Capital deeply engages in post-investment management. It leverages the collaborative network among super-node companies in its B2B investment portfolio to drive rapid enterprise growth, forming an investment strategy known as the “Dong Ting Lake Fund B2B Synergy Group,” thereby becoming an active participant in promoting industrial transformation.

Shenzhen Jiufite Private Equity Investment Management Co., Ltd. was established in June 2015 and currently manages four operating RMB-denominated funds. Jiufite specializes in pre-IPO equity investments, targeting industries aligned with national policy support, possessing strong growth prospects, and meeting the development needs of listed companies. The firm enhances the value of its portfolio companies through post-investment management. To date, it has completed investments in nearly 20 projects, with several having successfully achieved initial public offerings (IPOs) or initiated the IPO filing process. Its investment activities are primarily concentrated in the Yangtze River Delta, the Pearl River Delta, and the Bohai Rim regions. The firm focuses on seven emerging industrial sectors: energy conservation and environmental protection, next-generation information technology, new energy and new energy vehicles, high-end equipment manufacturing, new materials, pharmaceuticals and healthcare, and biotechnology. Leveraging its robust resource integration capabilities, Jiufite’s management team works closely with listed companies, aiming to use investment as a link and value-added services as a means to help enterprises establish competitive advantages, thereby achieving win-win outcomes for both businesses and investors.

CEC Capital is a leading new-economy investment bank in China, focusing on three major sectors globally: TMT, consumer, and healthcare. In addition to its investment banking services, CEC Capital manages one RMB-denominated fund and one U.S. dollar-denominated fund. The firm has offices in Beijing, Shanghai, Los Angeles, and San Francisco, and holds a license to operate in the U.S. securities market.

The healthcare and medical sector is a key focus area where CEC CAPITAL holds significant competitive advantages. Our diverse team, composed of professionals from R&D, investment funds, medical institutions, and corporate groups, enables CEC CAPITAL to possess profound understanding and insight into the healthcare industry and its investment logic.